RHUMBLINE ADVISERS - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 50 filers reported holding OVID THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$317,909
+23.0%
82,791
+5.1%
0.00%
Q2 2023$258,359
+31.1%
78,768
+60.8%
0.00%
Q1 2021$197,000
+71.3%
48,990
-1.4%
0.00%
Q4 2020$115,000
-56.8%
49,670
+7.3%
0.00%
Q3 2020$266,000
-25.1%
46,280
-4.0%
0.00%
-100.0%
Q2 2020$355,000
+1083.3%
48,225
+183.5%
0.00%
Q1 2019$30,000
-25.0%
17,010
+2.8%
0.00%
Q4 2018$40,000
-37.5%
16,551
+47.2%
0.00%
Q3 2018$64,000
-30.4%
11,241
-4.9%
0.00%
Q2 2018$92,00011,8160.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
TLS Advisors LLC 1,319,679$4,32918.57%
Madison Avenue Partners, LP 3,307,605$10,848,9432.37%
CHI Advisors LLC 864,822$2,836,6160.86%
Rubric Capital Management LP 5,445,910$17,862,5850.76%
BVF INC/IL 6,851,051$22,471,4470.63%
EcoR1 Capital, LLC 6,117,400$20,065,0720.49%
Artal Group S.A. 2,500,000$8,2000.25%
Tejara Capital Ltd 112,591$369,2980.18%
DCF Advisers, LLC 64,764$212,4260.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 801,152$2,627,7790.06%
View complete list of OVID THERAPEUTICS INC shareholders